Massachusetts governor roils PhRMA with law on drug firm payments
This article was originally published in Scrip
Executive Summary
Massachusetts Governor Deval Patrick was in the spotlight earlier this summer when he signed into law a bill that invests $1 billion over 10 years in the state's life sciences community. Now just two months later he is facing the wrath of BIO, PhRMAand the Massachusetts Biotechnology Council (MBC) with the signing of a bill that contains language that will force companies to disclose any gifts or payments over $50 that they provide to doctors – and which all of the groups believe will interfere with collaborations that have been essential to the expansion of this sector in the state.